Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Bulletin Barbados.
Press releases published on July 21, 2025
StablR Secures Strategic Investment from Kraken as Stablecoin Adoption Surges
GlobeNewswire
·
July 21, 2025
AMSTERDAM, July 21, 2025 (GLOBE NEWSWIRE) -- StablR, a leading European stablecoin issuer, proudly announces a strategic investment from Kraken, a technology platform built on crypto that unlocks access and reduces inefficiencies to drive financial freedom …
Cologix Closes $525 Million USD Asset-Backed Securitization to Support AI Infrastructure, Interconnection and Growth
GlobeNewswire
·
July 21, 2025
DENVER, July 21, 2025 (GLOBE NEWSWIRE) -- Cologix, a leading network-neutral interconnection and hyperscale edge data center company in North America, today announced that it has closed a $525 million USD asset-backed securitization (ABS) to support the …
Cologix conclut une titrisation adossée à des actifs de 525 millions de dollars américains pour soutenir l’infrastructure, l’interconnexion et la croissance de l’IA
GlobeNewswire
·
July 21, 2025
DENVER, 21 juill. 2025 (GLOBE NEWSWIRE) -- Cologix, le chef de file nord-américain d’interconnexions neutres et des centres de données hyperscale edge, a annoncé aujourd’hui qu’elle a conclu une titrisation, adossée à des actifs sécurisés (ABS), de 525 …
Longeveron® Announces Licensing of New Cardiac Selective Induced Pluripotent Stem Cell Technology for Cardiovascular Disease
GlobeNewswire
·
July 21, 2025
Longeveron has licensed issued US Patent 12,168,028 B2, entitled “Methods for obtaining cardiomyogenic precursor cells” from the University of Miami New patent protects a method to derive GHRH-Receptor+ cardiomyogenic cells from pluripotent stem cells ( …
CentralReach Adds Workforce Management System Viventium to Preferred Partnership Network
GlobeNewswire
·
July 21, 2025
Fort Lauderdale, FL, July 21, 2025 (GLOBE NEWSWIRE) -- CentralReach, a leading provider of Autism and IDD Care software for ABA, multidisciplinary, and special education, today announced a new preferred partnership with Viventium, an industry-leading …
Edge Conversion Launches Custom AI Systems to Supercharge Sales and Scale Growth for Small Businesses
GlobeNewswire
·
July 21, 2025
Los Angeles, California, July 21, 2025 (GLOBE NEWSWIRE) -- Edge Conversion, an emerging AI automation agency based in Los Angeles, has unveiled a suite of tailored AI systems that simplify operations and supercharge growth for service-based and online …
FloQast Named to CNBC’s 2025 List of World’s Top Fintech Companies in Enterprise Category
GlobeNewswire
·
July 21, 2025
LOS ANGELES, July 21, 2025 (GLOBE NEWSWIRE) -- FloQast, an Accounting Transformation Platform created by accountants for accountants, today announced it has been named to CNBC’s 2025 list of the World’s Top Fintech Companies, securing a spot in the …
Connect Biopharma Announces Plans to Terminate its American Depositary Receipt Program and Directly List its Ordinary Shares on Nasdaq
GlobeNewswire
·
July 21, 2025
SAN DIEGO, July 21, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a clinical-stage biopharmaceutical company focused on transforming care for the treatment of inflammatory diseases, today …
Senti Bio’s Chief Medical Officer, Kanya Rajangam, M.D., Ph.D. to Give Feature Presentation at the BioScience Forum
GlobeNewswire
·
July 21, 2025
SOUTH SAN FRANCISCO, Calif., July 21, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene …
Vor Bio Appoints Biotech Industry Leaders Alexander (Bo) Cumbo and Michel Detheux, Ph.D. to Board of Directors
GlobeNewswire
·
July 21, 2025
- New board members bring decades of experience in company building, corporate strategy, commercialization, and business development CAMBRIDGE, Mass., July 21, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company …
Bit Origin Acquires Over 40 Million Dogecoin (DOGE) to Advance Treasury Strategy
GlobeNewswire
·
July 21, 2025
SINGAPORE, July 21, 2025 (GLOBE NEWSWIRE) -- Bit Origin Ltd (NASDAQ: BTOG) ("Bit Origin" or the "Company"), today announced the initial purchase of approximately 40.5 million DOGE. This represents the first strategic acquisition under the Company's digital …
Urteste S.A. Completes Development of Panuri Test – Company Plans to Launch Clinical Study in Q3 2025
GlobeNewswire
·
July 21, 2025
Urteste S.A. Completes Development of Panuri Test – Company Plans to Launch Clinical Study in Q3 2025 Gdańsk, Poland - July 21, 2025 - Urteste S.A. (Warsaw Stock Exchange: URT), a company specializing in the development of innovative technology for cancer …
Arbe to Announce Second Quarter 2025 Financial Results and to Hold a Conference Call on August 7, 2025
GlobeNewswire
·
July 21, 2025
Tel Aviv, Israel, July 21, 2025 — Arbe Robotics Ltd. (Nasdaq, TASE: ARBE), a global leader in perception radar solutions, today announced that it will hold its second quarter 2025 conference call on Thursday, August 7, 2025 at 8:30 a.m. Eastern Time. The …
UroGen Announces Five-Year Long-Term Extension Study of the OPTIMA II Trial Demonstrates Long-Term Durability of Response to ZUSDURI™ in Patients with Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
GlobeNewswire
·
July 21, 2025
Findings published in the journal of Clinical Genitourinary Cancer show patients remained event-free for a median of two years after achieving complete response with ZUSDURI (mitomycin) intravesical solution. Among the 17 patients who achieved complete …
NKGen Receives FDA Expanded Access Protocol Authorization for Landmark Treatment of Several Neurodegenerative Diseases
GlobeNewswire
·
July 21, 2025
Troculeucel, a cryopreserved, autologous enhanced natural killer cell therapy, has demonstrated preliminary clinical benefit without any drug-related adverse events in two Phase I clinical trials in Alzheimer’s Disease. Company receives expanded access …
Ardelyx to Report Second Quarter 2025 Financial Results on August 4, 2025
GlobeNewswire
·
July 21, 2025
WALTHAM, Mass., July 21, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today …
Disc Medicine Announces Positive Pre-NDA Meeting and Confirms Plans to Submit NDA for Bitopertin in Erythropoietic Protoporphyria (EPP) in October 2025
GlobeNewswire
·
July 21, 2025
WATERTOWN, Mass., July 21, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious …
ArriVent’s Topline Pivotal Phase 3 FURVENT Data for Firmonertinib in First-Line NSCLC EGFR Exon20 Insertion Mutations is Projected to be Early 2026
GlobeNewswire
·
July 21, 2025
Enrollment in FURVENT was completed in Q1 2025 Firmonertinib received FDA Breakthrough Therapy Designation in this patient population NEWTOWN SQUARE, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc. (Company or ArriVent) (Nasdaq: AVBP), a …
Korro Receives European Medicines Agency Orphan Drug Designation for KRRO-110
GlobeNewswire
·
July 21, 2025
CAMBRIDGE, Mass., July 21, 2025 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA for both rare and highly prevalent diseases, …
Expanding Analyst Interest in ORYZON
GlobeNewswire
·
July 21, 2025
MADRID and CAMBRIDGE, Mass., July 21, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, Ticker: ORY), a clinical-stage biopharmaceutical company and a European leader in epigenetics, today announced that Maxim LLC, a U.S.-based …